Idogen AB
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
- Pharmaceuticals
See more in Biomedtracker
Latest on Idogen AB
Scrip
• By Kevin Grogan
The future of Idogen AB hangs in the balance with the Swedish firm's critical financial situation leaving its lead clinical-stage development program IDO 8 for hemophilia in limbo. Idogen's announce
Scrip
• By Mandy Jackson
Biotechnology stocks in the US are still trading lower year-to-date, but valuations have risen significantly in April, suggesting that perhaps the winter chill hovering over the industry is beginning